Accurate, molecular detection in minutes for Point of Care and Home use

AscellaOne Test

We are a medical diagnostics company with rapid, low cost molecular testing technology that may be implemented in both Point of Care and Home Use settings. In recent years, the pandemic has changed the course of healthcare, and Ascella strives to make access to infectious disease testing as convenient and as accessible as possible.

Picture1.png
Picture2.png

How it Works

AscellaOne Point of Care and Home Use, relies on a unique sample treatment, a proprietary primer design program specific for isothermal amplification, optimized chemistry and fluorescence read over time on a handheld device, proving a reliable test with fast (less than 10 minutes) and accurate results. AscellaOne is a one-stop solution for a range of diseases and variants due to parallel detection with multiple channels.

Versatility of Technology

Antibioticresistant
bacteria
Respiratory Viruses
Influenza
COVID-19
Common Cold
STIs
Screen Shot 2022-10-17 at 6.08.10 PM.png

Molecular Detection

Screen Shot 2022-10-17 at 6.09.36 PM.png

Rapid

Results

Screen Shot 2022-10-17 at 6.12.45 PM.png

Affordable Prices

Screen Shot 2022-10-17 at 6.14.54 PM.png

Why Ascella

Revolutionary Bioinformatic Pipeline +

Pathbreaking Chemistry

Screen Shot 2022-10-18 at 2.41.54 PM.png

RAMP™ Technology

PCR-level sensitivity and specificity

Ascella Biosystems has developed a breakthrough diagnostic platform that can quickly and inexpensively test for multiple pathogens from a single sample within minutes. Developed by world-renowned chemistry and physics experts at Stanford University, the company’s core Rapid Amplified Molecular Pathogen (RAMP) detection technology offers sensitivity and specificity comparable to PCR.

Proprietary Primer Design Software

Enables detection and identification of new diseases and variants in real time 

Rapid design of new, highly specific primers

Drastically reduces time for implementation of 

tests for new pathogens or variants

Built-in cross-reactivity and inclusivity checks

850COVIDVariantsGettyImages-1304835356.jpeg
Picture2.png

Integrated Mobile Application

The AscellaOne device has an intuitive design and a bluetooth-enabled app that is user friendly and inclusive for people with disabilities.

Bluetooth enabled

Immediate test results

User-friendly

Video Instructions

Applications

How the AscellaOne test can revolutionize testing in key industries

Screen Shot 2022-10-18 at 4.44.12 PM.png

Travel

Travelers can use AscellaOne to submit test results directly to airlines and travel authorities right before departure. Testing can continue while traveling and at the end of the trip.
Screen Shot 2022-10-19 at 2.47.14 PM.png

Events

Sporting events and concerts are often the primary sites for massive disease spread. Using AscellaOne can help mitigate this spread of disease through fast and convenient testing at entry points.

 
Screen Shot 2022-10-18 at 4.45.48 PM.png

Education

AscellaOne can be used at schools and universities to test students and faculty providing faster and more reliable results. This reduces the negative impact of the pandemic on the daily routines of these institutions.

About Us

We are led by a team of passionate researchers with broad experience in molecular biology, biochemistry, and hardware engineering. Our team includes world renowned chemistry experts from Stanford University and a hardware team with decades of medical device experience.

We are supported by leading Silicon Valley investors and the National Institutes of Health.

NIH_Master_Logo_Vertical_2Color.png
Stanford_University_logo_PNG9.png

Subscribe to our newsletter
to get all the updates and news about Ascella.

Thanks for submitting!